nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—HTR3A—Memantine—Alzheimer's disease	0.321	0.575	CbGbCtD
Palonosetron—CYP2D6—Alzheimer's disease	0.285	1	CbGaD
Palonosetron—CYP2D6—Rivastigmine—Alzheimer's disease	0.0625	0.112	CbGbCtD
Palonosetron—CYP2D6—Donepezil—Alzheimer's disease	0.05	0.0896	CbGbCtD
Palonosetron—CYP3A4—Rivastigmine—Alzheimer's disease	0.0397	0.0713	CbGbCtD
Palonosetron—CYP2D6—Galantamine—Alzheimer's disease	0.0322	0.0578	CbGbCtD
Palonosetron—CYP3A4—Donepezil—Alzheimer's disease	0.0318	0.057	CbGbCtD
Palonosetron—CYP3A4—Galantamine—Alzheimer's disease	0.0205	0.0367	CbGbCtD
Palonosetron—Praziquantel—CYP2D6—Alzheimer's disease	0.00174	1	CrCbGaD
Palonosetron—Hypokalaemia—Galantamine—Alzheimer's disease	0.000769	0.00512	CcSEcCtD
Palonosetron—Fluid retention—Rivastigmine—Alzheimer's disease	0.000761	0.00507	CcSEcCtD
Palonosetron—Gastritis—Galantamine—Alzheimer's disease	0.000748	0.00498	CcSEcCtD
Palonosetron—Hot flush—Donepezil—Alzheimer's disease	0.0007	0.00466	CcSEcCtD
Palonosetron—Menopausal symptoms—Donepezil—Alzheimer's disease	0.000694	0.00462	CcSEcCtD
Palonosetron—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000659	0.00439	CcSEcCtD
Palonosetron—Hot flush—Memantine—Alzheimer's disease	0.000635	0.00423	CcSEcCtD
Palonosetron—Menopausal symptoms—Memantine—Alzheimer's disease	0.00063	0.0042	CcSEcCtD
Palonosetron—Urinary retention—Donepezil—Alzheimer's disease	0.000623	0.00415	CcSEcCtD
Palonosetron—Hot flush—Rivastigmine—Alzheimer's disease	0.000622	0.00414	CcSEcCtD
Palonosetron—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.000616	0.00411	CcSEcCtD
Palonosetron—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000616	0.0041	CcSEcCtD
Palonosetron—Epistaxis—Galantamine—Alzheimer's disease	0.000614	0.00409	CcSEcCtD
Palonosetron—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000598	0.00398	CcSEcCtD
Palonosetron—Hypokalaemia—Donepezil—Alzheimer's disease	0.000596	0.00397	CcSEcCtD
Palonosetron—Bradycardia—Galantamine—Alzheimer's disease	0.000595	0.00396	CcSEcCtD
Palonosetron—Pain in extremity—Memantine—Alzheimer's disease	0.000594	0.00396	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00059	0.00393	CcSEcCtD
Palonosetron—Pain in extremity—Rivastigmine—Alzheimer's disease	0.000582	0.00387	CcSEcCtD
Palonosetron—Gastritis—Donepezil—Alzheimer's disease	0.000579	0.00386	CcSEcCtD
Palonosetron—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000577	0.00385	CcSEcCtD
Palonosetron—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000574	0.00383	CcSEcCtD
Palonosetron—Urethral disorder—Galantamine—Alzheimer's disease	0.000573	0.00382	CcSEcCtD
Palonosetron—Abdominal distension—Donepezil—Alzheimer's disease	0.00057	0.0038	CcSEcCtD
Palonosetron—Urinary retention—Memantine—Alzheimer's disease	0.000565	0.00377	CcSEcCtD
Palonosetron—Urinary retention—Rivastigmine—Alzheimer's disease	0.000553	0.00368	CcSEcCtD
Palonosetron—Eye disorder—Galantamine—Alzheimer's disease	0.000546	0.00364	CcSEcCtD
Palonosetron—Tinnitus—Galantamine—Alzheimer's disease	0.000545	0.00363	CcSEcCtD
Palonosetron—Cardiac disorder—Galantamine—Alzheimer's disease	0.000542	0.00361	CcSEcCtD
Palonosetron—Hypokalaemia—Memantine—Alzheimer's disease	0.000541	0.0036	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000535	0.00357	CcSEcCtD
Palonosetron—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000531	0.00354	CcSEcCtD
Palonosetron—Angiopathy—Galantamine—Alzheimer's disease	0.00053	0.00353	CcSEcCtD
Palonosetron—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000529	0.00353	CcSEcCtD
Palonosetron—Immune system disorder—Galantamine—Alzheimer's disease	0.000528	0.00352	CcSEcCtD
Palonosetron—Gastritis—Memantine—Alzheimer's disease	0.000526	0.00351	CcSEcCtD
Palonosetron—Arrhythmia—Galantamine—Alzheimer's disease	0.000522	0.00348	CcSEcCtD
Palonosetron—Gastritis—Rivastigmine—Alzheimer's disease	0.000515	0.00343	CcSEcCtD
Palonosetron—Mental disorder—Galantamine—Alzheimer's disease	0.000512	0.00341	CcSEcCtD
Palonosetron—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00051	0.0034	CcSEcCtD
Palonosetron—Malnutrition—Galantamine—Alzheimer's disease	0.000509	0.00339	CcSEcCtD
Palonosetron—Flatulence—Galantamine—Alzheimer's disease	0.000501	0.00334	CcSEcCtD
Palonosetron—Dysgeusia—Galantamine—Alzheimer's disease	0.000498	0.00332	CcSEcCtD
Palonosetron—Epistaxis—Donepezil—Alzheimer's disease	0.000476	0.00317	CcSEcCtD
Palonosetron—Anaemia—Galantamine—Alzheimer's disease	0.00047	0.00313	CcSEcCtD
Palonosetron—Hyperglycaemia—Memantine—Alzheimer's disease	0.000463	0.00309	CcSEcCtD
Palonosetron—Bradycardia—Donepezil—Alzheimer's disease	0.000461	0.00307	CcSEcCtD
Palonosetron—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000453	0.00302	CcSEcCtD
Palonosetron—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000447	0.00298	CcSEcCtD
Palonosetron—Urethral disorder—Donepezil—Alzheimer's disease	0.000444	0.00296	CcSEcCtD
Palonosetron—Convulsion—Galantamine—Alzheimer's disease	0.000441	0.00294	CcSEcCtD
Palonosetron—Hypertension—Galantamine—Alzheimer's disease	0.000439	0.00293	CcSEcCtD
Palonosetron—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000433	0.00289	CcSEcCtD
Palonosetron—Arthralgia—Galantamine—Alzheimer's disease	0.000433	0.00289	CcSEcCtD
Palonosetron—Myalgia—Galantamine—Alzheimer's disease	0.000433	0.00289	CcSEcCtD
Palonosetron—Epistaxis—Memantine—Alzheimer's disease	0.000432	0.00288	CcSEcCtD
Palonosetron—Anxiety—Galantamine—Alzheimer's disease	0.000432	0.00288	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00043	0.00287	CcSEcCtD
Palonosetron—Sinusitis—Memantine—Alzheimer's disease	0.00043	0.00286	CcSEcCtD
Palonosetron—Discomfort—Galantamine—Alzheimer's disease	0.000428	0.00285	CcSEcCtD
Palonosetron—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000424	0.00282	CcSEcCtD
Palonosetron—Dry mouth—Galantamine—Alzheimer's disease	0.000424	0.00282	CcSEcCtD
Palonosetron—Epistaxis—Rivastigmine—Alzheimer's disease	0.000423	0.00282	CcSEcCtD
Palonosetron—Tinnitus—Donepezil—Alzheimer's disease	0.000422	0.00281	CcSEcCtD
Palonosetron—Sinusitis—Rivastigmine—Alzheimer's disease	0.00042	0.0028	CcSEcCtD
Palonosetron—Bradycardia—Memantine—Alzheimer's disease	0.000419	0.00279	CcSEcCtD
Palonosetron—Bradycardia—Rivastigmine—Alzheimer's disease	0.00041	0.00273	CcSEcCtD
Palonosetron—Shock—Galantamine—Alzheimer's disease	0.000409	0.00272	CcSEcCtD
Palonosetron—Nervous system disorder—Galantamine—Alzheimer's disease	0.000407	0.00271	CcSEcCtD
Palonosetron—Chills—Donepezil—Alzheimer's disease	0.000406	0.00271	CcSEcCtD
Palonosetron—Urinary tract disorder—Memantine—Alzheimer's disease	0.000406	0.00271	CcSEcCtD
Palonosetron—Tachycardia—Galantamine—Alzheimer's disease	0.000405	0.0027	CcSEcCtD
Palonosetron—Arrhythmia—Donepezil—Alzheimer's disease	0.000405	0.0027	CcSEcCtD
Palonosetron—Connective tissue disorder—Memantine—Alzheimer's disease	0.000404	0.00269	CcSEcCtD
Palonosetron—Skin disorder—Galantamine—Alzheimer's disease	0.000403	0.00269	CcSEcCtD
Palonosetron—Urethral disorder—Memantine—Alzheimer's disease	0.000403	0.00269	CcSEcCtD
Palonosetron—Alopecia—Donepezil—Alzheimer's disease	0.0004	0.00267	CcSEcCtD
Palonosetron—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000397	0.00265	CcSEcCtD
Palonosetron—Mental disorder—Donepezil—Alzheimer's disease	0.000397	0.00264	CcSEcCtD
Palonosetron—Anorexia—Galantamine—Alzheimer's disease	0.000396	0.00264	CcSEcCtD
Palonosetron—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000395	0.00263	CcSEcCtD
Palonosetron—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000394	0.00263	CcSEcCtD
Palonosetron—Erythema—Donepezil—Alzheimer's disease	0.000394	0.00263	CcSEcCtD
Palonosetron—Malnutrition—Donepezil—Alzheimer's disease	0.000394	0.00263	CcSEcCtD
Palonosetron—Flatulence—Donepezil—Alzheimer's disease	0.000389	0.00259	CcSEcCtD
Palonosetron—Hypotension—Galantamine—Alzheimer's disease	0.000388	0.00259	CcSEcCtD
Palonosetron—Dysgeusia—Donepezil—Alzheimer's disease	0.000386	0.00257	CcSEcCtD
Palonosetron—Eye disorder—Memantine—Alzheimer's disease	0.000384	0.00256	CcSEcCtD
Palonosetron—Tinnitus—Memantine—Alzheimer's disease	0.000383	0.00255	CcSEcCtD
Palonosetron—Cardiac disorder—Memantine—Alzheimer's disease	0.000382	0.00254	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000378	0.00252	CcSEcCtD
Palonosetron—Eye disorder—Rivastigmine—Alzheimer's disease	0.000376	0.00251	CcSEcCtD
Palonosetron—Insomnia—Galantamine—Alzheimer's disease	0.000376	0.0025	CcSEcCtD
Palonosetron—Tinnitus—Rivastigmine—Alzheimer's disease	0.000375	0.0025	CcSEcCtD
Palonosetron—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000373	0.00249	CcSEcCtD
Palonosetron—Angiopathy—Memantine—Alzheimer's disease	0.000373	0.00249	CcSEcCtD
Palonosetron—Paraesthesia—Galantamine—Alzheimer's disease	0.000373	0.00248	CcSEcCtD
Palonosetron—Immune system disorder—Memantine—Alzheimer's disease	0.000371	0.00247	CcSEcCtD
Palonosetron—Mediastinal disorder—Memantine—Alzheimer's disease	0.000371	0.00247	CcSEcCtD
Palonosetron—Somnolence—Galantamine—Alzheimer's disease	0.000369	0.00246	CcSEcCtD
Palonosetron—Chills—Memantine—Alzheimer's disease	0.000369	0.00246	CcSEcCtD
Palonosetron—Arrhythmia—Memantine—Alzheimer's disease	0.000367	0.00245	CcSEcCtD
Palonosetron—Dyspepsia—Galantamine—Alzheimer's disease	0.000365	0.00244	CcSEcCtD
Palonosetron—Angiopathy—Rivastigmine—Alzheimer's disease	0.000365	0.00243	CcSEcCtD
Palonosetron—Anaemia—Donepezil—Alzheimer's disease	0.000364	0.00243	CcSEcCtD
Palonosetron—Alopecia—Memantine—Alzheimer's disease	0.000363	0.00242	CcSEcCtD
Palonosetron—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000363	0.00242	CcSEcCtD
Palonosetron—Chills—Rivastigmine—Alzheimer's disease	0.000361	0.00241	CcSEcCtD
Palonosetron—Decreased appetite—Galantamine—Alzheimer's disease	0.000361	0.0024	CcSEcCtD
Palonosetron—Mental disorder—Memantine—Alzheimer's disease	0.00036	0.0024	CcSEcCtD
Palonosetron—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000359	0.00239	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000358	0.00239	CcSEcCtD
Palonosetron—Malnutrition—Memantine—Alzheimer's disease	0.000358	0.00239	CcSEcCtD
Palonosetron—Fatigue—Galantamine—Alzheimer's disease	0.000358	0.00239	CcSEcCtD
Palonosetron—Alopecia—Rivastigmine—Alzheimer's disease	0.000356	0.00237	CcSEcCtD
Palonosetron—Constipation—Galantamine—Alzheimer's disease	0.000355	0.00237	CcSEcCtD
Palonosetron—Flatulence—Memantine—Alzheimer's disease	0.000353	0.00235	CcSEcCtD
Palonosetron—Mental disorder—Rivastigmine—Alzheimer's disease	0.000352	0.00235	CcSEcCtD
Palonosetron—Dysgeusia—Memantine—Alzheimer's disease	0.000351	0.00234	CcSEcCtD
Palonosetron—Malnutrition—Rivastigmine—Alzheimer's disease	0.00035	0.00233	CcSEcCtD
Palonosetron—Erythema—Rivastigmine—Alzheimer's disease	0.00035	0.00233	CcSEcCtD
Palonosetron—Flatulence—Rivastigmine—Alzheimer's disease	0.000345	0.0023	CcSEcCtD
Palonosetron—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000343	0.00229	CcSEcCtD
Palonosetron—Convulsion—Donepezil—Alzheimer's disease	0.000342	0.00228	CcSEcCtD
Palonosetron—Hypertension—Donepezil—Alzheimer's disease	0.00034	0.00227	CcSEcCtD
Palonosetron—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00034	0.00226	CcSEcCtD
Palonosetron—Myalgia—Donepezil—Alzheimer's disease	0.000336	0.00224	CcSEcCtD
Palonosetron—Arthralgia—Donepezil—Alzheimer's disease	0.000336	0.00224	CcSEcCtD
Palonosetron—Anxiety—Donepezil—Alzheimer's disease	0.000335	0.00223	CcSEcCtD
Palonosetron—Discomfort—Donepezil—Alzheimer's disease	0.000332	0.00221	CcSEcCtD
Palonosetron—Anaemia—Memantine—Alzheimer's disease	0.000331	0.0022	CcSEcCtD
Palonosetron—Dry mouth—Donepezil—Alzheimer's disease	0.000328	0.00219	CcSEcCtD
Palonosetron—Abdominal pain—Galantamine—Alzheimer's disease	0.000328	0.00219	CcSEcCtD
Palonosetron—Body temperature increased—Galantamine—Alzheimer's disease	0.000328	0.00219	CcSEcCtD
Palonosetron—Anaemia—Rivastigmine—Alzheimer's disease	0.000324	0.00216	CcSEcCtD
Palonosetron—Infection—Donepezil—Alzheimer's disease	0.00032	0.00213	CcSEcCtD
Palonosetron—Shock—Donepezil—Alzheimer's disease	0.000317	0.00211	CcSEcCtD
Palonosetron—Nervous system disorder—Donepezil—Alzheimer's disease	0.000316	0.0021	CcSEcCtD
Palonosetron—Convulsion—Memantine—Alzheimer's disease	0.00031	0.00207	CcSEcCtD
Palonosetron—Hypertension—Memantine—Alzheimer's disease	0.000309	0.00206	CcSEcCtD
Palonosetron—Anorexia—Donepezil—Alzheimer's disease	0.000307	0.00204	CcSEcCtD
Palonosetron—Hypersensitivity—Galantamine—Alzheimer's disease	0.000306	0.00204	CcSEcCtD
Palonosetron—Myalgia—Memantine—Alzheimer's disease	0.000305	0.00203	CcSEcCtD
Palonosetron—Arthralgia—Memantine—Alzheimer's disease	0.000305	0.00203	CcSEcCtD
Palonosetron—Anxiety—Memantine—Alzheimer's disease	0.000304	0.00202	CcSEcCtD
Palonosetron—Convulsion—Rivastigmine—Alzheimer's disease	0.000303	0.00202	CcSEcCtD
Palonosetron—Hypertension—Rivastigmine—Alzheimer's disease	0.000302	0.00201	CcSEcCtD
Palonosetron—Discomfort—Memantine—Alzheimer's disease	0.000301	0.00201	CcSEcCtD
Palonosetron—Hypotension—Donepezil—Alzheimer's disease	0.000301	0.002	CcSEcCtD
Palonosetron—Arthralgia—Rivastigmine—Alzheimer's disease	0.000298	0.00199	CcSEcCtD
Palonosetron—Myalgia—Rivastigmine—Alzheimer's disease	0.000298	0.00199	CcSEcCtD
Palonosetron—Dry mouth—Memantine—Alzheimer's disease	0.000298	0.00199	CcSEcCtD
Palonosetron—Asthenia—Galantamine—Alzheimer's disease	0.000298	0.00198	CcSEcCtD
Palonosetron—Anxiety—Rivastigmine—Alzheimer's disease	0.000297	0.00198	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000296	0.00197	CcSEcCtD
Palonosetron—Discomfort—Rivastigmine—Alzheimer's disease	0.000295	0.00196	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000293	0.00195	CcSEcCtD
Palonosetron—Dry mouth—Rivastigmine—Alzheimer's disease	0.000292	0.00194	CcSEcCtD
Palonosetron—Insomnia—Donepezil—Alzheimer's disease	0.000291	0.00194	CcSEcCtD
Palonosetron—Infection—Memantine—Alzheimer's disease	0.00029	0.00193	CcSEcCtD
Palonosetron—Paraesthesia—Donepezil—Alzheimer's disease	0.000289	0.00193	CcSEcCtD
Palonosetron—Shock—Memantine—Alzheimer's disease	0.000287	0.00192	CcSEcCtD
Palonosetron—Dyspnoea—Donepezil—Alzheimer's disease	0.000287	0.00191	CcSEcCtD
Palonosetron—Nervous system disorder—Memantine—Alzheimer's disease	0.000287	0.00191	CcSEcCtD
Palonosetron—Somnolence—Donepezil—Alzheimer's disease	0.000286	0.00191	CcSEcCtD
Palonosetron—Tachycardia—Memantine—Alzheimer's disease	0.000285	0.0019	CcSEcCtD
Palonosetron—Diarrhoea—Galantamine—Alzheimer's disease	0.000284	0.00189	CcSEcCtD
Palonosetron—Infection—Rivastigmine—Alzheimer's disease	0.000284	0.00189	CcSEcCtD
Palonosetron—Skin disorder—Memantine—Alzheimer's disease	0.000284	0.00189	CcSEcCtD
Palonosetron—Dyspepsia—Donepezil—Alzheimer's disease	0.000283	0.00189	CcSEcCtD
Palonosetron—Shock—Rivastigmine—Alzheimer's disease	0.000281	0.00187	CcSEcCtD
Palonosetron—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00028	0.00187	CcSEcCtD
Palonosetron—Decreased appetite—Donepezil—Alzheimer's disease	0.00028	0.00186	CcSEcCtD
Palonosetron—Tachycardia—Rivastigmine—Alzheimer's disease	0.000279	0.00186	CcSEcCtD
Palonosetron—Anorexia—Memantine—Alzheimer's disease	0.000279	0.00186	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000278	0.00185	CcSEcCtD
Palonosetron—Skin disorder—Rivastigmine—Alzheimer's disease	0.000278	0.00185	CcSEcCtD
Palonosetron—Fatigue—Donepezil—Alzheimer's disease	0.000277	0.00185	CcSEcCtD
Palonosetron—Constipation—Donepezil—Alzheimer's disease	0.000275	0.00183	CcSEcCtD
Palonosetron—Pain—Donepezil—Alzheimer's disease	0.000275	0.00183	CcSEcCtD
Palonosetron—Dizziness—Galantamine—Alzheimer's disease	0.000275	0.00183	CcSEcCtD
Palonosetron—Hypotension—Memantine—Alzheimer's disease	0.000273	0.00182	CcSEcCtD
Palonosetron—Anorexia—Rivastigmine—Alzheimer's disease	0.000272	0.00182	CcSEcCtD
Palonosetron—Hypotension—Rivastigmine—Alzheimer's disease	0.000267	0.00178	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000266	0.00177	CcSEcCtD
Palonosetron—Insomnia—Memantine—Alzheimer's disease	0.000264	0.00176	CcSEcCtD
Palonosetron—Vomiting—Galantamine—Alzheimer's disease	0.000264	0.00176	CcSEcCtD
Palonosetron—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000263	0.00175	CcSEcCtD
Palonosetron—Paraesthesia—Memantine—Alzheimer's disease	0.000262	0.00175	CcSEcCtD
Palonosetron—Rash—Galantamine—Alzheimer's disease	0.000262	0.00174	CcSEcCtD
Palonosetron—Dermatitis—Galantamine—Alzheimer's disease	0.000262	0.00174	CcSEcCtD
Palonosetron—Dyspnoea—Memantine—Alzheimer's disease	0.00026	0.00174	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00026	0.00174	CcSEcCtD
Palonosetron—Headache—Galantamine—Alzheimer's disease	0.00026	0.00173	CcSEcCtD
Palonosetron—Somnolence—Memantine—Alzheimer's disease	0.00026	0.00173	CcSEcCtD
Palonosetron—Insomnia—Rivastigmine—Alzheimer's disease	0.000259	0.00172	CcSEcCtD
Palonosetron—Dyspepsia—Memantine—Alzheimer's disease	0.000257	0.00171	CcSEcCtD
Palonosetron—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000257	0.00171	CcSEcCtD
Palonosetron—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000255	0.0017	CcSEcCtD
Palonosetron—Abdominal pain—Donepezil—Alzheimer's disease	0.000254	0.00169	CcSEcCtD
Palonosetron—Body temperature increased—Donepezil—Alzheimer's disease	0.000254	0.00169	CcSEcCtD
Palonosetron—Somnolence—Rivastigmine—Alzheimer's disease	0.000254	0.00169	CcSEcCtD
Palonosetron—Decreased appetite—Memantine—Alzheimer's disease	0.000254	0.00169	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000252	0.00168	CcSEcCtD
Palonosetron—Fatigue—Memantine—Alzheimer's disease	0.000252	0.00168	CcSEcCtD
Palonosetron—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000252	0.00168	CcSEcCtD
Palonosetron—Constipation—Memantine—Alzheimer's disease	0.00025	0.00166	CcSEcCtD
Palonosetron—Pain—Memantine—Alzheimer's disease	0.00025	0.00166	CcSEcCtD
Palonosetron—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000248	0.00166	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000247	0.00164	CcSEcCtD
Palonosetron—Nausea—Galantamine—Alzheimer's disease	0.000247	0.00164	CcSEcCtD
Palonosetron—Fatigue—Rivastigmine—Alzheimer's disease	0.000246	0.00164	CcSEcCtD
Palonosetron—Pain—Rivastigmine—Alzheimer's disease	0.000244	0.00163	CcSEcCtD
Palonosetron—Constipation—Rivastigmine—Alzheimer's disease	0.000244	0.00163	CcSEcCtD
Palonosetron—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000239	0.00159	CcSEcCtD
Palonosetron—Hypersensitivity—Donepezil—Alzheimer's disease	0.000237	0.00158	CcSEcCtD
Palonosetron—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000234	0.00156	CcSEcCtD
Palonosetron—Abdominal pain—Memantine—Alzheimer's disease	0.000231	0.00154	CcSEcCtD
Palonosetron—Body temperature increased—Memantine—Alzheimer's disease	0.000231	0.00154	CcSEcCtD
Palonosetron—Asthenia—Donepezil—Alzheimer's disease	0.000231	0.00154	CcSEcCtD
Palonosetron—Pruritus—Donepezil—Alzheimer's disease	0.000228	0.00152	CcSEcCtD
Palonosetron—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000226	0.00151	CcSEcCtD
Palonosetron—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000226	0.00151	CcSEcCtD
Palonosetron—Diarrhoea—Donepezil—Alzheimer's disease	0.00022	0.00147	CcSEcCtD
Palonosetron—Hypersensitivity—Memantine—Alzheimer's disease	0.000215	0.00143	CcSEcCtD
Palonosetron—Dizziness—Donepezil—Alzheimer's disease	0.000213	0.00142	CcSEcCtD
Palonosetron—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000211	0.0014	CcSEcCtD
Palonosetron—Asthenia—Memantine—Alzheimer's disease	0.00021	0.0014	CcSEcCtD
Palonosetron—Pruritus—Memantine—Alzheimer's disease	0.000207	0.00138	CcSEcCtD
Palonosetron—Asthenia—Rivastigmine—Alzheimer's disease	0.000205	0.00137	CcSEcCtD
Palonosetron—Vomiting—Donepezil—Alzheimer's disease	0.000205	0.00136	CcSEcCtD
Palonosetron—Rash—Donepezil—Alzheimer's disease	0.000203	0.00135	CcSEcCtD
Palonosetron—Dermatitis—Donepezil—Alzheimer's disease	0.000203	0.00135	CcSEcCtD
Palonosetron—Pruritus—Rivastigmine—Alzheimer's disease	0.000202	0.00135	CcSEcCtD
Palonosetron—Headache—Donepezil—Alzheimer's disease	0.000202	0.00134	CcSEcCtD
Palonosetron—Diarrhoea—Memantine—Alzheimer's disease	0.0002	0.00133	CcSEcCtD
Palonosetron—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000196	0.0013	CcSEcCtD
Palonosetron—Dizziness—Memantine—Alzheimer's disease	0.000193	0.00129	CcSEcCtD
Palonosetron—Nausea—Donepezil—Alzheimer's disease	0.000191	0.00127	CcSEcCtD
Palonosetron—Dizziness—Rivastigmine—Alzheimer's disease	0.000189	0.00126	CcSEcCtD
Palonosetron—Vomiting—Memantine—Alzheimer's disease	0.000186	0.00124	CcSEcCtD
Palonosetron—Rash—Memantine—Alzheimer's disease	0.000184	0.00123	CcSEcCtD
Palonosetron—Dermatitis—Memantine—Alzheimer's disease	0.000184	0.00123	CcSEcCtD
Palonosetron—Headache—Memantine—Alzheimer's disease	0.000183	0.00122	CcSEcCtD
Palonosetron—Vomiting—Rivastigmine—Alzheimer's disease	0.000182	0.00121	CcSEcCtD
Palonosetron—Rash—Rivastigmine—Alzheimer's disease	0.00018	0.0012	CcSEcCtD
Palonosetron—Dermatitis—Rivastigmine—Alzheimer's disease	0.00018	0.0012	CcSEcCtD
Palonosetron—Headache—Rivastigmine—Alzheimer's disease	0.000179	0.00119	CcSEcCtD
Palonosetron—Nausea—Memantine—Alzheimer's disease	0.000174	0.00116	CcSEcCtD
Palonosetron—Nausea—Rivastigmine—Alzheimer's disease	0.00017	0.00113	CcSEcCtD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000136	0.0248	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000119	0.0216	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000116	0.0212	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000116	0.0211	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000116	0.0211	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000112	0.0204	CbGpPWpGaD
Palonosetron—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00011	0.02	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—MAP2—Alzheimer's disease	9.85e-05	0.018	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	9.83e-05	0.0179	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	9.24e-05	0.0168	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	9.15e-05	0.0167	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	9.07e-05	0.0165	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	8.97e-05	0.0163	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	8.3e-05	0.0151	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—HSD17B10—Alzheimer's disease	8.22e-05	0.015	CbGpPWpGaD
Palonosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	8.17e-05	0.0149	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	7.99e-05	0.0146	CbGpPWpGaD
Palonosetron—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	7.89e-05	0.0144	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	7.55e-05	0.0138	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	7.53e-05	0.0137	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	7.45e-05	0.0136	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TF—Alzheimer's disease	7.45e-05	0.0136	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	7e-05	0.0128	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP2D6—Alzheimer's disease	6.83e-05	0.0125	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—SST—Alzheimer's disease	6.81e-05	0.0124	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	6.81e-05	0.0124	CbGpPWpGaD
Palonosetron—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	6.65e-05	0.0121	CbGpPWpGaD
Palonosetron—CYP1A2—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	6.57e-05	0.012	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	6.52e-05	0.0119	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	6.4e-05	0.0117	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	6.35e-05	0.0116	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	6.31e-05	0.0115	CbGpPWpGaD
Palonosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	6.3e-05	0.0115	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	6.12e-05	0.0112	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	5.54e-05	0.0101	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—ACHE—Alzheimer's disease	5.52e-05	0.0101	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	5.27e-05	0.00961	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen Receptor Pathway—ESR1—Alzheimer's disease	5.25e-05	0.00957	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	5.23e-05	0.00954	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	5.19e-05	0.00945	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	5.08e-05	0.00926	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	5.08e-05	0.00925	CbGpPWpGaD
Palonosetron—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	5.07e-05	0.00924	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	4.94e-05	0.009	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	4.88e-05	0.0089	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	4.87e-05	0.00888	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—MAOB—Alzheimer's disease	4.72e-05	0.0086	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	4.72e-05	0.0086	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—APOD—Alzheimer's disease	4.71e-05	0.00858	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	4.51e-05	0.00822	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	4.3e-05	0.00783	CbGpPWpGaD
Palonosetron—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	4.11e-05	0.00748	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	4e-05	0.00729	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	3.88e-05	0.00706	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	3.65e-05	0.00666	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	3.64e-05	0.00664	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.43e-05	0.00625	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	3.43e-05	0.00625	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	3.42e-05	0.00623	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	3.35e-05	0.0061	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	3.25e-05	0.00593	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	3.21e-05	0.00585	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	3.1e-05	0.00564	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	2.99e-05	0.00545	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	2.96e-05	0.00539	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.96e-05	0.00539	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	2.91e-05	0.00529	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	2.89e-05	0.00527	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	2.84e-05	0.00517	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	2.8e-05	0.0051	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	2.77e-05	0.00505	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	2.76e-05	0.00502	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	2.72e-05	0.00495	CbGpPWpGaD
Palonosetron—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	2.71e-05	0.00493	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.55e-05	0.00464	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.54e-05	0.00463	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.52e-05	0.00458	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	2.51e-05	0.00457	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	2.39e-05	0.00435	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	2.39e-05	0.00435	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	2.37e-05	0.00432	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	2.35e-05	0.00427	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	2.3e-05	0.00419	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	2.22e-05	0.00405	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	2.19e-05	0.00399	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	2.16e-05	0.00394	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.16e-05	0.00393	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	2.13e-05	0.00387	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	2.1e-05	0.00382	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	1.94e-05	0.00354	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	1.91e-05	0.00348	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.85e-05	0.00337	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	1.81e-05	0.0033	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	1.78e-05	0.00323	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.76e-05	0.00321	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	1.71e-05	0.00312	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	1.64e-05	0.003	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	1.59e-05	0.00289	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.49e-05	0.00272	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	1.47e-05	0.00268	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	1.37e-05	0.0025	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	1.28e-05	0.00234	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	1.28e-05	0.00232	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	1.27e-05	0.00231	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	1.25e-05	0.00227	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	1.22e-05	0.00223	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.21e-05	0.0022	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	1.15e-05	0.00209	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	1.08e-05	0.00197	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	1.06e-05	0.00193	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	9.92e-06	0.00181	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	9.62e-06	0.00175	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	9.43e-06	0.00172	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.3e-06	0.00169	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	9.26e-06	0.00169	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	9.26e-06	0.00169	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	8.34e-06	0.00152	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CA4—Alzheimer's disease	7.09e-06	0.00129	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	7.06e-06	0.00129	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	6.66e-06	0.00121	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.59e-06	0.0012	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	6.32e-06	0.00115	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLD3—Alzheimer's disease	6.03e-06	0.0011	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CA4—Alzheimer's disease	6.01e-06	0.00109	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.87e-06	0.00107	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	5.78e-06	0.00105	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	5.65e-06	0.00103	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	5.56e-06	0.00101	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.45e-06	0.000993	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ND1—Alzheimer's disease	5.37e-06	0.000979	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	5.35e-06	0.000975	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLD3—Alzheimer's disease	5.11e-06	0.00093	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.11e-06	0.00093	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.05e-06	0.00092	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	4.9e-06	0.000892	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.78e-06	0.000872	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	4.71e-06	0.000859	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.63e-06	0.000844	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ND1—Alzheimer's disease	4.55e-06	0.000829	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.45e-06	0.00081	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.36e-06	0.000794	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.13e-06	0.000753	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.07e-06	0.000741	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.94e-06	0.000718	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.78e-06	0.000688	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.64e-06	0.000663	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.51e-06	0.00064	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.51e-06	0.000639	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TPI1—Alzheimer's disease	3.46e-06	0.000631	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CHAT—Alzheimer's disease	3.46e-06	0.000631	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MAOB—Alzheimer's disease	3.32e-06	0.000605	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	3.19e-06	0.000582	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.19e-06	0.000582	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—A2M—Alzheimer's disease	3.09e-06	0.000562	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CHAT—Alzheimer's disease	2.93e-06	0.000534	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TPI1—Alzheimer's disease	2.93e-06	0.000534	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MAOB—Alzheimer's disease	2.81e-06	0.000512	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	2.71e-06	0.000493	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ACHE—Alzheimer's disease	2.68e-06	0.000489	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.68e-06	0.000488	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	2.65e-06	0.000483	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.65e-06	0.000483	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—A2M—Alzheimer's disease	2.61e-06	0.000476	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ENO1—Alzheimer's disease	2.52e-06	0.000458	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	2.52e-06	0.000458	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BCHE—Alzheimer's disease	2.34e-06	0.000426	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.33e-06	0.000425	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.27e-06	0.000414	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.26e-06	0.000412	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.26e-06	0.000412	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.25e-06	0.00041	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.21e-06	0.000402	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.17e-06	0.000395	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.14e-06	0.00039	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.13e-06	0.000388	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.13e-06	0.000388	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.09e-06	0.000381	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.09e-06	0.000381	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.02e-06	0.000368	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.98e-06	0.000361	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.87e-06	0.000341	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	1.84e-06	0.000336	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	1.83e-06	0.000334	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.83e-06	0.000334	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.81e-06	0.00033	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.75e-06	0.00032	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.73e-06	0.000316	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.68e-06	0.000306	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.64e-06	0.0003	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.64e-06	0.0003	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.61e-06	0.000294	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.56e-06	0.000285	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.55e-06	0.000283	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.53e-06	0.000279	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.51e-06	0.000275	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.44e-06	0.000263	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.42e-06	0.000259	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.41e-06	0.000257	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.41e-06	0.000256	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.4e-06	0.000255	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.39e-06	0.000254	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.28e-06	0.000233	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.23e-06	0.000223	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.21e-06	0.00022	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INS—Alzheimer's disease	1.2e-06	0.000219	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.2e-06	0.000219	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.2e-06	0.000218	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.19e-06	0.000217	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.18e-06	0.000215	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.1e-06	0.0002	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.05e-06	0.000192	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.04e-06	0.000189	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INS—Alzheimer's disease	1.02e-06	0.000186	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.88e-07	0.00018	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	9.64e-07	0.000176	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.23e-07	0.000168	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.2e-07	0.000168	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.11e-07	0.000166	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NOS3—Alzheimer's disease	8.93e-07	0.000163	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.17e-07	0.000149	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.01e-07	0.000146	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INS—Alzheimer's disease	7.86e-07	0.000143	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.89e-07	0.000126	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.3e-07	0.000115	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—Alzheimer's disease	4.84e-07	8.83e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.1e-07	7.48e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.17e-07	5.77e-05	CbGpPWpGaD
